To study the efficacy of single pulse rTMS in migraine prophylaxis

Randomized placebo controlled trial evaluating role of single pulse rTMS in migraine prophylaxis

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/12/003165

Enrollment

Registered

2012-12-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Migraine headache patients with more than 4 attacks/month.

Interventions

Intervention1: Repetitive transcranial magnetic stimulation: Patients left prefrontal cortex will be stimulated by repetitive transcranial magnetic coil(Magstim Rapid, Whitland, Wales, UK). Each sessi

Eligibility

Inclusion criteria

Inclusion criteria: Patients of migraine headache with frequency of attacks more than four attcaks per month

Exclusion criteria

Exclusion criteria: Children less then 18 years, pregnancy, liver or kidney diseases, malignancy, severe hypertension, pacemaker or metallic implants and history of seizure or structural brain lesions

Design outcomes

Primary

Measure	Time frame
1. More than 50% improvement in frequency of headache 2. Global improvement in VASTimepoint: 1 month	—

Secondary

Measure	Time frame
Severity of headache, Functional improvement, rescue analgesic intake and somatosensory evoked potential before and after rTMS in selected patientsTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr U K Misra

Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)

drukmisra@rediffmail.com0522-2494167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026